Moneycontrol
HomeNewsIndiaLav Agarwal, face of Centre’s fight against coronavirus, tests COVID-19 positive
Trending Topics
Akhilesh Yadav
Amit Shah
Mallikarjun Kharge
Himachal Landslide
CJI BR Gavai
UK PM India Visit

Lav Agarwal, face of Centre’s fight against coronavirus, tests COVID-19 positive

The IAS officer who was a part of daily media briefings on India's coronavirus response is in home isolation at present and has urged all the persons he met to self-monitor for COVID-19 symptoms.

Moneycontrol News
August 14, 2020 / 22:40 IST
Story continues below Advertisement
Remove Ad

Ministry of Health and Family Welfare Joint Secretary Lav Agarwal, who has been the face of the Centre’s fight against coronavirus, has tested COVID-19 positive.

Story continues below Advertisement
Remove Ad

The IAS officer took to Twitter on August 14 to announce that he has tested positive for the infectious disease that has killed more than 48,000 persons in India since its outbreak.

For live updates on coronavirus, click here
He is in home isolation at present and has urged all the persons he met to self-monitor for COVID-19 symptoms.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
 View more
+ Show

Agarwal has been a part of the daily media briefings on coronavirus and COVID-19 response through April and May. He had also visited several states since the outbreak of the infectious disease to assess their COVID-19 response system and suggest ways on how to improve them.

Story continues below Advertisement
Remove Ad
Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.